Related Experiment Video
Updated: Aug 6, 2026

09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
Development of in vitro immunization in murine and human hybridoma technology
1Department of Biotechnology, University of Lund, P.O. Box 124, S-221 00 Lund, Sweden.
Journal of Pharmaceutical and Biomedical Analysis
|January 1, 1987
Abstract:
The development of in vitro immunization in murine and human hybridoma technology is reviewed. Special consideration is given to: technical aspects of in vitro immunization of mouse B cells; quality of antibodies produced by in vitro immunization; advantages of murine in vitro immunization; technical aspects of in vitro immunization of human B cells; and the advantages of human in vitro immunization and human monoclonal antibodies. Future developments likely to be made in this area of immunotechnology are outlined.

